$49.95 $1.66 per serving
Product analysis
LFG Burn Tropical uses caffeine to support short-term alertness and exercise performance. The complex mixtures have unknown proportions, making some added ingredients harder to compare.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality33
Several ingredient sources are named, but that does not confirm the quality of the full performance mixture. Missing forms and mixture proportions leave the preparation less clearly characterized.
Ingredient Transparency71
All listed amounts and most ingredient forms are disclosed. Unknown proportions within the caffeine, sodium and botanical mixtures prevent a complete composition comparison.
Value For Money31
Caffeine and Alpha-GPC offer poor value at the serving price, while huperzine offers more moderate value. Value for many remaining ingredients is uncertain, so the long list does not establish a better buy.
Customer Satisfaction72
Ratings are positive, but the small number of reviews limits confidence. A small pool of opinions cannot establish a typical experience or health benefit.
Product Focus33
Caffeine provides the clearest immediate contribution to alertness and exercise. The 300 mg serving may add jitteriness or anxiety, while a single serving does not reproduce weeks of beta-alanine use.
- Format
Powder - Container
- 10 Ounce(s)
- Per serving
- $1.66
- Customer rating
- 4.8 · 11 ratings
Goals
Impact
High effect
Beta-Alanine · 3200 mgCaffeine · 300 mg
Caffeine can acutely improve exercise performance, most consistently endurance, while strength and sprint responses vary. The declared 300 mg serving reaches the saved fixed-amount comparison, which is not a personal body-weight dose. Beta-alanine at 3200 mg contributes toward repeated loading for high-intensity efforts lasting about one to four minutes; a single pre-workout serving does not establish that effect. Arginine is counted, but its performance evidence remains conflicting.
How this product is rated for Fitness
Ingredient fit57
The formula includes counted exercise or nutritional ingredients alongside components aimed at broader goals. Their serving amounts provide different levels of contribution.
Goal fit
The formula includes counted exercise or nutritional ingredients alongside components aimed at broader goals.
Dose adequacy
The disclosed serving amounts contribute to different acute, repeated-use or nutritional comparisons; they do not establish a single proven regimen.
Pathways80
The strongest recorded area is central drive and fatigue perception. Coverage also reaches the listed exercise areas.
Depth
The strongest recorded area is central drive and fatigue perception.
Breadth
The main recorded areas are muscle energy and buffering, central drive and fatigue perception.
Evidence91
Beta-alanine provides the strongest counted evidence here, tied to repeated loading and high-intensity efforts rather than immediate pre-workout benefit.
Evidence strength
Beta-alanine provides the strongest counted evidence here, tied to repeated loading and high-intensity efforts rather than immediate pre-workout benefit.
Studied preparation
The saved findings recognize the counted preparations; this does not remove their population, regimen or endpoint limitations.
Formulation logic100
The counted ingredients have no missing required partner or configured conflict, and all meet the saved minimum amount comparison.
Partner coverage
The counted ingredients have no missing required partner for their assigned contributions.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients meet the saved minimum amount comparison; this does not mean every ingredient has proven exercise benefits.
Beta-Alanine Not classified
No linked studies yet.
Impact
High effect
Caffeine · 300 mg
Caffeine can produce a modest, temporary rise in energy expenditure. The serving supplies 300 mg, but more caffeine does not establish a proportionally larger effect or lasting weight loss. Grains of paradise acts on heat-sensing pathways, although the supplied information does not establish what this preparation and amount contribute.
How this product is rated for Metabolism Support
Ingredient fit60
Caffeine is the principal direct thermogenic ingredient, and its amount reaches the saved comparison range. Other actives make the formula less focused on this goal.
Goal fit
Caffeine provides the direct connection to temporary thermogenesis; several other actives serve different purposes.
Dose adequacy
The declared caffeine amount reaches the saved comparison range; a larger serving amount does not establish a larger metabolic effect.
Pathways51
Caffeine provides the main connection through temporary stimulation of energy expenditure.
Depth
Caffeine provides the main connection through temporary stimulation of energy expenditure.
Breadth
Only the caffeine-related stimulation pathway reaches the saved coverage threshold.
Evidence66
Caffeine has direct human evidence for a modest acute thermogenic effect; sustained weight loss is not established.
Evidence strength
Caffeine has direct human evidence for a modest acute thermogenic effect; sustained weight loss is not established.
Studied preparation
The saved finding accepts the caffeine preparation; it does not establish an added benefit from microencapsulation.
Formulation logic100
No unmet partner requirement or configured conflict was found, and the recognized ingredients meet the saved amount threshold.
Partner coverage
The recognized ingredients have no unmet partner requirement in the saved findings; this does not establish additional benefit from combining them.
Conflicts
No configured ingredient conflict was detected in the supplied facts.
Effective doses
The recognized ingredients reach the saved amount threshold; that threshold does not establish a clinically effective thermogenic dose.
Impact
High effect
Huperzine · 200 mcgAlpha-GPC · 200 mgCaffeine · 300 mg
Caffeine supports short-term alertness and attention, although tolerance, timing and sleep loss can change the outcome. These attention findings do not establish sustained work output. Alpha-GPC has narrow cognitive-test evidence, but its active-content and preparation requirements limit comparisons with this declaration.
How this product is rated for Productivity Boost
Ingredient fit67
Caffeine gives the formula a clear connection to alertness, while its broader ingredient mix or linked uses affect overall focus.
Goal fit
The formula has a broader purpose, with other active ingredients or multiple linked uses reducing its concentration on this goal.
Dose adequacy
Most declared amounts reach the saved comparison range, with some receiving partial recognition.
Pathways60
The strongest connection is short-term alertness, with limited breadth across other cognitive routes.
Depth
Short-term alertness is the strongest represented route.
Breadth
Only one assessed route reaches meaningful coverage, so the findings do not show broad support across different aspects of productivity.
Evidence65
Caffeine provides the clearest relevant evidence for acute attention. Preparation limitations affect other ingredients where applicable.
Evidence strength
Caffeine supplies the strongest recognized evidence here, focused on acute attention rather than sustained work output.
Studied preparation
Only part of the eligible formula matches the saved preparation criteria; other declarations have preparation or active-content limitations.
Formulation logic93
The higher caffeine amount triggers a conflict finding, even though counted ingredients meet the saved amount threshold.
Partner coverage
No missing ingredient partner limits the saved finding; this does not demonstrate an added benefit from combining ingredients.
Conflicts
The caffeine amount triggers the higher-caffeine conflict finding; additional caffeine does not establish better work performance.
Effective doses
The counted ingredients reach the saved minimum amount threshold, which is a comparison criterion rather than proof of benefit.
Impact
Highest effect
Caffeine · 300 mg
Caffeine helps increase alertness and reduce sleepiness. Beta-alanine relates to resisting fatigue during high-intensity exercise, with benefits studied after repeated daily use over weeks. The serving supplies 300 mg caffeine and 3200 mg beta-alanine, but one serving does not reproduce a multiweek exercise protocol. Caffeine response also depends on tolerance, timing and sensitivity; the two caffeine forms do not establish added benefit.
How this product is rated for Energy
Ingredient fit66
The formula’s relevance depends on its energy-related ingredients and their declared amounts.
Goal fit
Energy-related ingredients sit within a broader formula, limiting its specific focus on this goal.
Dose adequacy
The relevant declared amounts reach the full comparison range; this does not establish larger benefits or a treatment dose.
Pathways80
Caffeine provides the main contribution through increased wakefulness.
Depth
Caffeine provides the main contribution through increased wakefulness.
Breadth
Two distinct routes were recognized, with their practical benefits depending on the ingredients and use conditions.
Evidence100
Caffeine provides the strongest evidence connection here, subject to the population and benefit limits described above.
Evidence strength
Caffeine provides the strongest evidence connection here, subject to the population and benefit limits described above.
Studied preparation
The recognized preparations matched the saved comparison; this does not establish superiority of particular forms.
Formulation logic100
The recognized ingredients have their required support, with no configured conflict identified.
Partner coverage
The recognized ingredients have no missing required partner in these findings.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All recognized ingredients meet the saved minimum amount threshold; that threshold does not prove clinical benefit.
Beta-Alanine Not classified
No linked studies yet.
Impact
Moderate effect
Caffeine · 300 mg
300 mg of caffeine may temporarily increase heat production and energy expenditure. Habitual use can reduce its effects, and a short-term increase in calorie burning does not guarantee sustained weight loss. The 10 mg Paradoxine declaration differs from the named grains of paradise preparation used in the supplied weight-management evidence.
How this product is rated for Weight Loss
Ingredient fit60
Caffeine is the main reviewed contributor, alongside several ingredients aimed at other purposes. Caffeine reaches the saved amount reference.
Goal fit
Caffeine is the main reviewed contributor, alongside several ingredients aimed at other purposes.
Dose adequacy
Caffeine reaches the saved amount reference.
Pathways48
Heat production and energy expenditure are the strongest connection. Only heat production and energy expenditure reach the saved threshold for substantial coverage; other connections are weaker.
Depth
Heat production and energy expenditure are the strongest connection.
Breadth
Only heat production and energy expenditure reach the saved threshold for substantial coverage; other connections are weaker.
Evidence62
Caffeine provides the strongest evidence contribution in the saved findings, with more support for short-term energy expenditure than lasting weight reduction. The saved findings recognize the preparations of the reviewed contributors at qualifying amounts.
Evidence strength
Caffeine provides the strongest evidence contribution in the saved findings, with more support for short-term energy expenditure than lasting weight reduction.
Studied preparation
The saved findings recognize the preparations of the reviewed contributors at qualifying amounts.
Formulation logic100
No configured ingredient conflict was matched in the saved findings. All reviewed contributors meet the saved minimum amount threshold; that threshold is not a guarantee of weight loss.
Partner coverage
The reviewed contributors have no unmet partner requirement in the saved findings.
Conflicts
No configured ingredient conflict was matched in the saved findings.
Effective doses
All reviewed contributors meet the saved minimum amount threshold; that threshold is not a guarantee of weight loss.
Impact
High effect
Alpha-GPC · 200 mgCaffeine · 300 mgHuperzine · 200 mcg
Caffeine supports alertness and sustained attention. Alpha-GPC has limited, exercise-specific findings, and its declared material does not establish the active preparation used in that trial; huperzine's mechanism does not establish acute focus improvement in healthy adults. The 300 mg caffeine serving raises the prospect of jitteriness and anxiety without further attention gain.
How this product is rated for Mental Focus
Ingredient fit72
Caffeine provides the clearest focus connection, alongside less certain cholinergic ingredients in a broader exercise formula. Caffeine and huperzine reach their saved amount ranges; Alpha-GPC receives a smaller amount contribution without confirmed active preparation.
Goal fit
Caffeine provides the clearest focus connection, alongside less certain cholinergic ingredients in a broader exercise formula.
Dose adequacy
Caffeine and huperzine reach their saved amount ranges; Alpha-GPC receives a smaller amount contribution without confirmed active preparation.
Pathways60
Alertness is the strongest finding; the cholinergic contribution is smaller.
Depth
Alertness is the strongest finding; the cholinergic contribution is smaller.
Breadth
Alertness is the only substantially covered route; cholinergic signalling remains below that level.
Evidence68
Caffeine provides the strongest acute attention evidence. Caffeine matches the studied category; the Alpha-GPC and huperzine declarations do not establish matching acute-focus preparations.
Evidence strength
Caffeine provides the strongest acute attention evidence.
Studied preparation
Caffeine matches the studied category; the Alpha-GPC and huperzine declarations do not establish matching acute-focus preparations.
Formulation logic93
All three credited ingredients meet the saved amount threshold, which does not prove each improves focus. The 300 mg caffeine serving raises jitteriness and anxiety concerns without further attention gain.
Partner coverage
The credited ingredients work alone or have their required partner in the saved findings.
Conflicts
The 300 mg caffeine serving raises jitteriness and anxiety concerns without further attention gain.
Effective doses
All three credited ingredients meet the saved amount threshold, which does not prove each improves focus.
Huperzine Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Sodium (Himalayan Rock Salt, Sodium Citrate) | 80 mg | |
Beta-Alanine | 3200 mg | |
Nitrosigine (Inositol-Stabilized Arginine Silicate) | 1500 mg | |
Caffeine (Caffeine Anhydrous, Caffeine Anhydrous, Microencapsulated) | 300 mg | |
MitoBurn (Beta-Aminoisobutyric Acid) | 250 mg | |
AlphaSize Alpha GPC | 200 mg | |
Mucuna pruriens extract (L-Dopa) | 100 mg | |
AstraGin (Astragalus membranaceous, Panax notoginseng) | 25 mg | |
Paradoxine (Grains of Paradise) | 10 mg | |
Huperzine A | 200 mcg |
Huperzine · 200 mcg OverallScore53
Alpha-GPC · 200 mg OverallScore67
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
- Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
- Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
- [Drug evaluation of huperzine A in the treatment of senile memory disorders].
- Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine.
- Caffeine-containing energy drink improves physical performance of elite rugby players during a simulated match.
- Differential cognitive effects of energy drink ingredients: caffeine, taurine, and glucose.
- Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study.
- Trait Energy and Fatigue Modify the Effects of Caffeine on Mood, Cognitive and Fine-Motor Task Performance: A Post-Hoc Study.
- The effect of L-arginine supplementation on maximal oxygen uptake: A systematic review and meta-analysis.